Navigation Links
Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008
Date:7/9/2008

Most Surveyed MCO Pharmacy Directors Will Move Razadyne and Razadyne ER from Tier 2 to Tier 3 When Generic Razadyne is Launched, According to a New

Report from Decision Resources

WALTHAM, Mass., July 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the generic availability of Shire/Janssen/Ortho McNeil's Razadyne (galantamine) in December 2008 will have the greatest impact on Eisai/Pfizer's Aricept as surveyed primary care physicians (PCPs) estimate that after the launch of generic galantamine, prescriptions of Aricept for the treatment of Alzheimer's disease will drop by up to 20 percent. According to the new Physician & Payer Forum primary market research report entitled The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer's Disease Market: Clinician and Payer Receptivity to Novel Agents, the availability of generic galantamine will decrease Aricept's share of PCPs' prescriptions for Alzheimer's disease patients from 66 percent to 46 percent by December 2009. The report also finds that for surveyed neurologists, Aricept's share of prescriptions for Alzheimer's disease patients will fall from 62 percent to 44 percent.

According to the report, more than two-thirds of managed care organizations (MCOs) that cover Razadyne and Razadyne ER in their private plan formularies grant these agents tier 2 status. When generic galantamine becomes available, many surveyed MCO pharmacy directors indicated that they will move both Razadyne formulations to tier 3. Additionally, nearly one quarter of surveyed MCO pharmacy directors said they will remove Razadyne ER from their private plan formularies, and more than one third will remove Razadyne, when generic galantamine becomes available. The percentage of pharmacy directors who reported they will remove Razadyne ER and Razadyne from their
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
2. Study finds primary care depression treatment often does not follow quality guidelines
3. Primary biliary cirrhosis more severe in African-American and Hispanic patients
4. New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families
5. Revisions to College Cost Reduction and Access Act will create barriers to primary care
6. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
7. Editorial says primary care system must change how it approaches dementia
8. S&P: Leverage Tops Politics as Primary Credit Concern for U.S. Health Care Companies, Says S&P
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. Visual field loss primary component in risk of falls for older adults
11. Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... Beverly Hills licensed Clinical Psychologist and ... 20 years of private practice in her Beverly Hills ... achieve greater joy and fulfillment in their relationships. Dr. ... and suggestions for anyone who suspects they are in ... it or not, it’s not always easy to know ...
(Date:10/1/2014)... 01, 2014 NoteSwift Inc., announced today ... 10.0, 12.1 and 13.0. NoteSwift is the bridge between ... to navigate and document clinical information at the point ... creating a patient note by more than half – ... major pain points providers state impedes EHR use according ...
(Date:10/1/2014)... Ethiopia, at the occasion of the Leishmaniasis East ... African and international leishmaniasis experts, results of a ... monitoring plan, carried out by MSF, DNDi, ... Ethiopia, were presented to key decision makers in ... kala-azar with the combination of Sodium Stibogluconate and ...
(Date:10/1/2014)... Dr. Saj Jivraj, one of the ... traveling to Chennai, India, tomorrow to speak at the ... 3. , Dr. Jivraj is founder of the Anacapa ... and one of the world’s foremost prosthodontists, meaning he ... is speaking to the Indian Society of Oral Implantologists ...
Breaking Medicine News(10 mins):Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5
... 12 DARA,BioSciences, Inc. ("DARA") and Point Therapeutics, Inc. ... effective as,of the close of business on February 12, ... the respective stockholders,of DARA and Point. Immediately prior to ... split of its common stock pursuant to which,each 40 ...
... Ohio, Feb. 12 AtriCure, Inc.,(Nasdaq: ATRC ), ... surgical,ablation products, announced today that David J. Drachman, President ... Roth Capital,Partners 20th Annual OC Growth Stock Conference at ... Wednesday, February 20th at 2:00 p.m.,PT., A live ...
... tumors tend to survive longer and are more responsive ... to a study published online February 12 in the ... , Human papillomavirus has been shown to be involved ... particularly cancers of the upper throat, or oropharynx. Retrospective ...
... Deaths More Common Among Breast Cancer Survivors ... at greater risk of death from non-cancer causes ... cancer treatments improve, patients are surviving longer, and ... cancer. Judith-Anne Chapman, Ph.D., and colleagues with the ...
... 2008 -- In a study to examine the impact of ... report over one month, researchers at Columbia University Mailman School ... was a more accurate predictor of physically and mentally unhealthy ... to lose weight was more predictive of unhealthy days among ...
... to treatment than those with HPV-negative tumors , , TUESDAY, ... patients whose tumors test positive for human papillomavirus (HPV) ... than those who test negative, a new study says. ... be responsible for most cervical cancers, has recently been ...
Cached Medicine News:Health News:DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger 2Health News:AtriCure to Present at Roth Capital Partners 20th Annual OC Conference 2Health News:Other highlights in the Feb. 12 JNCI 2Health News:Other highlights in the Feb. 12 JNCI 3Health News:Other highlights in the Feb. 12 JNCI 4Health News:Body image is stronger predictor of health than obesity, says Mailman School of PH study 2
(Date:10/1/2014)... , Suisse, October 1, 2014 ... et dans le domaine de l,analyse des données ... aujourd,hui une solution de diagnostic in vitro (IVD) ... analyse complète de la mucoviscidose dans un seul ... de caractériser tous les types de variantes par ...
(Date:9/30/2014)... report analyzes the worldwide markets for Enteral Feeding Devices in ... Nasogastric Tubes, and Others. The report provides separate ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ... for these markets. The report profiles 38 companies ...
(Date:9/30/2014)... Sept. 30, 2014 MiMedx Group, Inc. (NASDAQ: ... utilizing human amniotic tissue and patent-protected processes to develop ... Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental ... , Ph.D., Chief Scientific Officer, will present at the ... present on Tuesday, October 7, 2014, at 5:00PM Pacific ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19MiMedx to Present at the Stem Cell Meeting on the Mesa 2
... Feb. 14, 2011 Thoratec Corporation (Nasdaq: THOR ... to save, support and restore failing hearts, announced today that ... to $100 million of the company,s shares of common stock ... confidence in the long-term strength of the company, as well ...
... 14, 2011 Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly cash dividend of 12 ... 15, 2011 to shareholders of record at the close ... Laboratories develops, acquires, manufactures and markets electronic instruments and ...
Cached Medicine Technology:Thoratec Corporation Authorizes $100 Million Share Repurchase Program 2Thoratec Corporation Authorizes $100 Million Share Repurchase Program 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: